CRISPR
CRISPR is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. Each sequence within an individual prokaryotic CRISPR is derived from a DNA fragment of a bacteriophage that had previously infected the prokaryote or one of its ancestors. These sequences are used to detect and destroy DNA from similar bacteriophages during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes and provide a form of heritable, acquired immunity. CRISPR is found in approximately 50% of sequenced bacterial genomes and nearly 90% of sequenced archaea.
Recent news mentioning CRISPR
- — Nabsys Announces First Publication Showcasing CRISPR/Cas9 Mediated Approach to Expand the Capabilities of Electronic Genome Mapping
- — 3 Reasons CRISPR Therapeutics Stock Is Still a Buy After a Rocky 2026
- — AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
- — Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
- — Axsome Therapeutics vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
- — Why CRISPR Therapeutics Stock Rocked the Market Last Month
- — Where Will CRISPR Therapeutics Stock Be in 5 Years?
- — IntelliGenome Appoints SIMED as Exclusive Distributor for CRISPR-TB™ in Peru and Ecuador
- — 2 Reasons CRISPR Therapeutics Stock Could Soar in the Final 4 Months of 2026
- — CRISPR Therapeutics Stock Is Up Only 8% This Year. Is Cathie Wood's Bet on the Gene-Editing Stock Dead Money?